Barr Pharmaceuticals
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (September 2008) |
Industry | Pharmaceuticals & Medical Devices |
---|---|
Founded | New York (1970) |
Headquarters | Montvale, NJ, USA |
Key people | Bruce Downey, CEO |
Products | Generic and Proprietary Pharmaceuticals |
Revenue | Over $1 Billion USD fiscal year 2005 |
Employees | 2000 |
[edit] History
Barr Laboratories, Inc. was founded in 1970 by Edwin A. Cohen and was ultimately taken public under his leadership.On July 18, 2008 it was announced that rival firm - Teva Pharmaceutical Industries Ltd, would acquire Barr Pharmaceuticals Inc for $7.46 billion plus the assumption of net debt of approximately $1.5 billion.[1] Today Barr Laboratories exists only as a sub-division of Teva Pharmaceuticals.
Teva Pharmaceuticals develops and markets generic pharmaceuticals under various brand names - including the Barr Laboratories, Inc. label. Teva Pharmaceuticals is the largest generic drug manufacturer in the world.
[edit] References
- ^ Staff (2008-07-21), "Teva Coughs Up $7.46B for Barr Reinforcing Its Number One Spot in the Generics Market", Genetic Engineering & Biotechnology News, GEN News Highlights (Mary Ann Liebert), ISSN 1937-8661, http://www.genengnews.com/news/bnitem.aspx?name=38938670, retrieved 2008-09-26